Press Releases

Headshot with text Brian Schimmoller named third Signature Science President and CEO

Signature Science Appoints New President, CEO

Schimmoller to be third president of SwRI subsidiary AUSTIN, TEXAS – March 8, 2022 – The Signature Science Managers Committee has unanimously elected Brian J. Schimmoller as the third president and CEO of the Austin-based company. Signature Science is a wholly owned subsidiary of Southwest Research Institute, specializing in national... MORE

IARPA funds Signature Science and Rice University to Develop SeqScreen-Nano Software to Analyze Long Reads...

Laptop-portable advanced computational tools will provide critical information beyond standard taxonomic classification to remote users with limited resources. AUSTIN, TEXAS – February 15, 2022 – Signature Science, LLC received funding from the Intelligence Advanced Research Projects Activity (IARPA) under the Functional Genomic and Computational Assessment of Threats (Fun GCAT) program... MORE
Photo of Jan Newton

Ms. Jan Newton Joins Signature Science’s Managers Committee

Newton previously served as President of AT&T Texas. AUSTIN, TEXAS – September 23, 2021 – Signature Science, LLC is pleased to announce the election of Ms. Jan Newton to its Managers Committee. Her career includes over 30 years of executive experience in finance, sales, marketing, regulatory affairs, and corporate governance.... MORE
Computer with Verogen Kintelligence software on screen

SigSci’s Center for Advanced Genomics Validating the Verogen ForenSeq® Kintelligence Workflow for Forensic Genetic Genealogy

New kit targets forensically relevant markers compatible with degraded and low-input DNA samples. AUSTIN, TEXAS – July 14, 2021 – Forensic scientists from the Center for Advanced Genomics (CAG) at Signature Science are validating the Verogen ForenSeq® Kintelligence workflow for the NDIS-approved MiSeq FGx® Sequencing System. ForenSeq Kintelligence, a new... MORE
Lab equipment with text "Fentanyl"

SigSci Awarded Contract to Develop Single-use Synthetic Opioid Detection System

AUSTIN, TEXAS – May 25, 2021 – The U.S. Navy has awarded a one-year, $292,814.70 contract to Signature Science for the development of a self-contained, single-use lateral flow immunoassay (LFA) system for the detection of synthetic opioids, such as fentanyl. First responders currently use procedures to detect synthetic opioids that... MORE